NASDAQ:NBRV Archives - BioPharmaJournal

Home Tags NASDAQ:NBRV

Nabriva Therapeutics plc (NASDAQ: NBRV) Receives marketing Approval for IV and...

Gavins Felicity - December 10, 2021 0

Nabriva Therapeutics Plc (NASDAQ:NBRV) Announced Q3 2020 Results And Updates On...

Ward Sport - November 17, 2020 0

Nabriva’s (NASDAQ:NBRV) XELENTA Shows Efficacy In Treating Community-Acquired Bacterial Pneumonia Patients...

Gavins Felicity - October 30, 2020 0

CMS Grants NTAP For Nabriva Therapeutics PLC (NASDAQ:NBRV)’s XENLETA For Injection

Gavins Felicity - September 23, 2020 0

Nabriva Therapeutics PLC (NASDAQ:NBRV) Inks A Pact With Amplity Health To...

Matt Wade - August 21, 2020 0

The European Commission (EC) Issues a Legal Binding Decision for the...

Gavins Felicity - July 31, 2020 0

Nabriva Therapeutics (NASDAQ:NBRV) Soars a Deal with Merck & Co., Inc....

Ward Sport - July 28, 2020 0

Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) Strikes a Marketing and Distribution...

Matt Wade - July 21, 2020 0

Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) Receive The FDA’s Response After...

Matt Wade - July 2, 2020 0

EU CHMP Gives Positive Opinion For Nabriva Therapeutics’(NASDAQ:NBRV) XENLETA In Community-Acquired...

Kate Hudson - June 10, 2020 0

Recent Post

Banking stocks in focus

Stocks In focus ahead as Wall Street grows hopeful of a...

Kate Hudson - May 26, 2023 0

The Invesco QQQ’s made new 12-month highs this morning and continue to climb. The QQQ’s are testing prior resistance of $347. It...

Best Stocks Alerts

Super Micro Computer’s Q4 Outlook ($SMCI) Boosts Investor Confidence Despite Q3...

May 3, 2023

IPOs are starting to heat up again (TRNR,GNLX,TCJH)

May 1, 2023

TOP Financial Group Limited ($TOP) surges over 600% after market hours

April 27, 2023

Best Stocks To Buy

Penny Stocks are back in focus (BBD,DIDIY,APE,TLRY,FCEL)

April 27, 2023